Experience of a Vasopressin Receptor Antagonist, Tolvaptan, Under the Unique Indication in Japanese Heart Failure Patients
2013 ◽
Vol 94
(4)
◽
pp. 449-451
◽
2015 ◽
Vol 46
(1)
◽
pp. 283-286
◽
1999 ◽
Vol 5
(3)
◽
pp. 51
◽
2002 ◽
Vol 450
(2)
◽
pp. 169-177
◽
2016 ◽
Vol 67
(13)
◽
pp. 1319
2008 ◽
Vol 14
(6)
◽
pp. S73
◽
Keyword(s):